Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KitazatoTSE:368A +0.79%22 Operating Margin % is 54.21% as of Mar. 2026, which is 2% below its 10-year median of 55.50. GuruFocus rates TSE:368A with a GF Score™ of 22/100. Among 815 Medical Devices & Instruments companies, Kitazato ranks better than 99.51% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Kitazato's Operating Income for the
six
months ended in Mar. 2026 was 円3,090 Mil. Kitazato's Revenue for the
six
months ended in Mar. 2026 was 円5,700 Mil. Therefore, Kitazato's Operating Margin % for the quarter that ended in Mar. 2026 was 54.21%.
The historical rank and industry rank for Kitazato's Operating Margin % or its related term are showing as below:
TSE:368A'
s Operating Margin % Range Over the Past 10 Years
Min: 53.52 Med: 55.5 Max: 58.66
Current: 53.52
TSE:368A's Operating Margin % is ranked better than 99.51% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 3.17
vs TSE:368A: 53.52
Kitazato's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Kitazato's Operating Income for the
six
months ended in Mar. 2026 was 円3,090 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was 円5,859 Mil.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Kitazato Operating Margin % Related Terms
Kitazato Operating Margin % Historical Data
* Premium members only.
The historical data trend for Kitazato's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:368A vs ISRG, BDX, MDLN: Operating Margin % Comparison
For the Medical Instruments & Supplies subindustry, Kitazato's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kitazato Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kitazato's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Kitazato's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Kitazato's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kitazato (TSE:368A) has a Operating Margin % of 54.21% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Kitazato and its competitors. This is near median its historical median of 55.50. Over the past decade, Kitazato's Operating Margin % has ranged from 53.52 to 58.66. According to the industry distribution chart, Kitazato ranks #4 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 0.5%.
Is Kitazato's Operating Margin % too high?
Kitazato's current Operating Margin % of 54.21% is near median its 10-year median of 55.50. Over the past 10 years, this metric has ranged from a low of 53.52 to a high of 58.66. The Medical Devices & Instruments industry median Operating Margin % is 3.17. Kitazato's value of 54.21% is 1610.1% above this industry median. Based on the distribution chart, Kitazato ranks #4 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Kitazato has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Kitazato's Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kitazato ranks #4 out of 815 companies for Operating Margin %. This places Kitazato in the top 1% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.17. Kitazato's value of 54.21% is 1610.1% above this benchmark. Historically, Kitazato's own Operating Margin % has ranged from 53.52 to 58.66 over the past decade. While the company's 10-year median is 55.50 vs. the industry median of 3.17, Kitazato has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.17, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kitazato's current Operating Margin % of 54.21% is 1610.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Kitazato and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kitazato's current Operating Margin % is 54.21%, which is near median its own 10-year median of 55.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kitazato stock overvalued right now?
Kitazato (TSE:368A) has a current Operating Margin % of 54.21%. The current Operating Margin % is 54.21%, which is near median its 10-year median of 55.50 and 1610.1% above the Medical Devices & Instruments industry median of 3.17. Kitazato's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Kitazato (TSE:368A), the current Operating Margin % is 54.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kitazato Corp is engaged in manufacture and sale of medical devices and related products for fertility treatment. Its products include Needles, Catheters and Cannulas, Vitrification Media and Equipments, Sperm Processing Medium/Tools, IVF Medium, etc.
22GF Score
Get the complete analysis for TSE:368A
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:368A has been successfully added to your 
